[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566548":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":19,"locations":29,"responsibleParty":42,"collaborators":44,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":80,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"prospective cervical cancer screening intervention","Evaluation of a cervical cancer screening outreach intervention using point-of-care High-Risk HPV (HPV-HR) tests on self-collected vaginal swabs",[12],"Other: HPV self sampling",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":18},"HPV self sampling","Selected women will perform a vaginal self-sampling using a swab",[9],null,[20,25],{"name":21,"role":22,"phone":23,"phoneExt":18,"email":24},"KARINE AMAT","CONTACT","0140256352","karine.amat@fondation-imea.org",{"name":26,"role":22,"phone":27,"phoneExt":18,"email":28},"Aïda BENALYCHERIF","0140256365","aida.benalycherif@fondation-imea.org",[30],{"facility":31,"status":18,"city":32,"state":18,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":18},"Hopital Avicenne","Bobigny","93000","France","FR",{"type":37,"coordinates":38},"Point",[39,40],2.45012,48.90982,{"lat":40,"lon":39},{"type":43,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[45,47,50,52],{"name":46,"class":6},"Hospital Avicenne",{"name":48,"class":49},"National Cancer Institute, France","OTHER_GOV",{"name":51,"class":6},"INSERM UMR S 1136",{"name":53,"class":49},"Institut National de la Santé Et de la Recherche Médicale, France","100566548","mobile-outreach-screening-of-high-risk-human-papillomavirus-infection-in-women-with-limited-access-to-health-services-in-seine-saint-denis-greater-paris-area-france-100566548",false,"NCT06656611","Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)","PAPMOBILE: Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health Services in Seine-Saint-Denis (greater Paris Area, France)","PAPMOBILE","Inclusion Criteria:\n\n* \\- Women from 30 to 65 years of age presenting to the \" Bus Santé \" nonclinical testing unit, eligible to cervical cancer screening by an HPV-HR test\n* Women affiliated to the French social security or immigrants benefiting from the state medical aid program for undocumented immigrants (Aide Médicale d'Etat). The inclusion of people not affiliated to a social security system is an exception and depends on the decision of the Personal Protection Committee, if it is based on an expected benefit for these people of a nature to justify the foreseeable risk incurred.\n* The intervention is designed for vulnerable women with limited access to healthcare, including but not limited to:\n\n  * Women living in shelters and hostels, women living in the streets, in squats, hot-bedding arrangements, emergency social housing;\n  * Recent immigrants, documented or undocumented;\n  * Young adults from priority neighbourhoods,\n  * Isolated or marginalized women\n* Free, informed, written consent, signed by the person and the investigator at the latest on the day of inclusion and before any sampling carried out as part of the trial (article L1122-1-1 of the Public Health Code)\n\nThe Bus will operate in underprivileged neighbourhoods in the greater Paris area (eastern Seine-Saint-Denis department.\n\nExclusion Criteria:\n\n* Screened for cervical cancer by a PAP smear in the last 3 years or by an HPV test in the last 5 years,\n* Women on their period (haemoglobin inhibits PCRs)\n* Pregnancy in the 2nd and 3rd trimesters\n* Total hysterectomy; absence of a vagina\n* Women under guardianship\u002Ftutelage",true,"FEMALE","30 Years","65 Years",{"count":67,"type":68},700,"ESTIMATED","INTERVENTIONAL",[71],"NA","The study is a prospective cervical cancer screening intervention in the nonclinical setting of a mobile testing unit in a vehicle, using point-of-care HPV PCR tests with self-collected vaginal swabs.\n\nIt is designed for women with limited access to healthcare and prevention in underprivileged municipalities in the greater Paris area (Seine-Saint-Denis department, detailed in Annexe 3).\n\nHPV positive participants will receive counseiling and guidance to help them find a healthcare professional to take care of their needs",[74],"Women's Health: Cervical Neoplasm",[76,77,78,79],"HPV","cervical cancer","outreach intervention","vaginal self sampling","NOT_YET_RECRUITING","2024-10-23",{"date":83,"type":84},"2024-10-24","ACTUAL",{"date":86,"type":68},"2024-12-01",{"date":88,"type":68},"2026-07-30",{"name":5,"class":6},1]